earnings
Early Growth Wins: Expanding Pipeline Offsets Legacy Headwinds (BMY Q1 2026 Earnings Call)
Bristol-Myers Squibb reported stable first-quarter financial performance, leveraging its expanding early-lifecycle growth portfolio to counter generic headwinds from legacy brands. Chief Executive Officer Christopher Boerner highlighted that the company is successfully improving its execution, focusing research efforts on life-threatening therapeutic solutions, and maintaining disciplined shareholder capital allocations.